Skip to main content
Log in

Lactobacillus plantarum Prevents the Upregulation of Adhesion Molecule Expression in an Experimental Colitis Model

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background

Lactobacillus consumption has been shown to attenuate the severity of experimental colitis. Whether the effects of Lactobacillus on colitis are related to modulation of leukocyte recruitment into the inflamed intestine is unclear.

Aims

To investigate the effect of Lactobacillus plantarum daily intragastric administration on lymphocyte homing and intestinal inflammation in interleukin 10 (IL-10) knockout mice, an experimental model of colitis.

Methods

Two groups of ten IL-10 knockout mice were fed phosphate buffered saline containing Lactobacillus plantarum 1258 or unmodified vehicle for 4 weeks. Two groups of ten wild-type mice were used as controls. At killing, the bowels were histologically scored and evaluated by transmission electron microscopy. Mucosal addressin cell adhesion molecule 1 (MAdCAM-1) and intercellular adhesion molecule 1 (ICAM-1) expression were determined by immunohistochemistry. The Levels of proinflammatory cytokines, tumor necrosis factor α (TNF-α), and interferon γ (IFN-γ) were determined by ELISA. In addition, levels of CD3, α4β7, ICAM-1, and MAdCAM-1 were determined by reverse-transcription polymerase chain reaction and Western blot.

Results

L. plantarum treatment improved the histological damage score in KO mice compared to untreated KO mice. L. plantarum significantly attenuated the expression of MAdCAM-1, ICAM-1, CD3, and α4β7, but did not affect the levels of TNF-α and IFN-γ when treated KO mice were compared to untreated KO mice.

Conclusions

L. plantarum interfered with the upregulation of adhesion molecules observed in IL-10 knockout mice compared to wild-type mice, attenuating the symptoms of colitis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Eksteen B, Liaskou E, Adams DH. Lymphocyte homing and its role in the pathogenesis of IBD. Inflamm Bowel Dis. 2008;14(9):1298–1312.

    Article  PubMed  Google Scholar 

  2. Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002;347(6):417–429.

    Article  PubMed  CAS  Google Scholar 

  3. Marteau P, Lepage P, Mangin I, et al. Review article: gut flora and inflammatory bowel disease. Aliment Pharmacol Ther. 2004;20(Suppl 4):18–23.

    Article  PubMed  Google Scholar 

  4. Favier C, Neut C, Mizon C, Cortot A, Colombel JF, Mizon J. Fecal beta-d-galactosidase production and Bifidobacteria are decreased in Crohn’s disease. Dig Dis Sci. 1997;42(4):817–822.

    Article  PubMed  CAS  Google Scholar 

  5. Cummings JH, Macfarlane GT, Macfarlane S. Intestinal bacteria and ulcerative colitis. Curr Issues Intest Microbiol. 2003;4(1):9–20.

    PubMed  CAS  Google Scholar 

  6. Martinez-Medina M, Aldeguer X, Gonzalez-Huix F, Acero D, Garcia-Gil LJ. Abnormal microbiota composition in the ileocolonic mucosa of Crohn’s disease patients as revealed by polymerase chain reaction-denaturing gradient gel electrophoresis. Inflamm Bowel Dis. 2006;12:1136–1145.

    Article  PubMed  Google Scholar 

  7. Sokol H, Seksik P, Rigottier-Gois L, et al. Specificities of the fecal microbiota in inflammatory bowel disease. Inflamm Bowel Dis. 2006;12:106–111.

    Article  PubMed  Google Scholar 

  8. Tamboli CP, Neut C, Desreumaux P, Colombel JF. Dysbiosis in inflammatory bowel disease. Gut. 2004;53:1–4.

    Article  PubMed  CAS  Google Scholar 

  9. Conte MP, Schippa S, Zamboni I, et al. Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease. Gut. 2006;55:1760–1767.

    Article  PubMed  CAS  Google Scholar 

  10. Pagnini C, Cominelli F. Probiotics in experimental and human inflammatory bowel disease: discussion points. Dig Liver Dis. 2006;38(Suppl 2):S270–S273.

    Article  PubMed  Google Scholar 

  11. Gionchetti P, Rizzello F, Venturi A, et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology. 2000;119:305–309.

    Article  PubMed  CAS  Google Scholar 

  12. Hilton E, Kolakowski P, Smith M, et al. Efficacy of Lactobacillus GG as a diarrheal preventative in travelers. J Travel Med. 1997;4:41–43.

    Article  PubMed  Google Scholar 

  13. Saavedra J. Probiotics and infectious diarrhea. Am J Gastroenterol. 2000;95:S16–S18.

    Article  PubMed  CAS  Google Scholar 

  14. Canducci F, Armuzzi A, Cremonini F, et al. A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates. Aliment Pharmacol Ther. 2000;14:1625–1629.

    Article  PubMed  CAS  Google Scholar 

  15. Fuller R. A review: probiotics in man and animals. J Appl Bacteriol. 1989;66:365–378.

    PubMed  CAS  Google Scholar 

  16. Guarner F, Schaafsma GJ. Probiotics. Int J Food Microbiol. 1998;39:237–238.

    Article  PubMed  CAS  Google Scholar 

  17. Metchnikoff E. The Prolongation of Life. Optimistic studies. London: William Heinemann; 1907.

    Google Scholar 

  18. Dunne C, O’Mahony L, Murphy L, et al. In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo findings. Am J Clin Nutr. 2001;73(2 Suppl):386S–392S.

    PubMed  CAS  Google Scholar 

  19. Vanderpool C, Yan F, Polk DB. Mechanisms of probiotic action: implications for therapeutic applications in inflammatory bowel diseases. Inflamm Bowel Dis. 2008;14(11):1585–1596.

    Article  PubMed  Google Scholar 

  20. Sheil B, Shanahan F, O’Mahony L. Probiotic effects on inflammatory bowel disease. J Nutr. 2007;137:819S–824S.

    PubMed  CAS  Google Scholar 

  21. Sartor RB. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology. 2004;126:1620–1633.

    Article  PubMed  Google Scholar 

  22. Angulo S, Llopis M, Antolín M, et al. Lactobacillus casei prevents the upregulation of ICAM-1 expression and leukocyte recruitment in experimental colitis. Am J Physiol Gastrointest Liver Physiol. 2006;291(6):G1155–G1162.

    Article  PubMed  CAS  Google Scholar 

  23. Butcher EC, Picker LJ. Lymphocyte homing and homeostasis. Science. 1996;272:60–66.

    Article  PubMed  CAS  Google Scholar 

  24. Salmi M, Jalkanen S. Lymphocyte homing to the gut: attraction, adhesion, and commitment. Immunol Rev. 2005;206:100–113.

    Article  PubMed  CAS  Google Scholar 

  25. Sackstein R. The lymphocyte homing receptors: gatekeepers of the multistep paradigm. Curr Opin Hematol. 2005;12:444–450.

    Article  PubMed  Google Scholar 

  26. Mora JR, von Andrian UH. T-cell homing specificity and plasticity: new concepts and future challenges. Trends Immunol. 2006;27:235–243.

    Article  PubMed  CAS  Google Scholar 

  27. Marelli-Berg FM, Cannella L, Dazzi F, Mirenda V. The highway code of T cell trafficking. J Pathol. 2008;214:179–189.

    Article  PubMed  CAS  Google Scholar 

  28. Marelli-Berg FM, Okkenhaug K, Mirenda V. A two-signal model for T cell trafficking. Trends Immunol. 2007;28:267–273.

    Article  PubMed  CAS  Google Scholar 

  29. Krüger K, Mooren FC. T cell homing and exercise. Exerc Immunol Rev. 2007;13:37–54.

    PubMed  Google Scholar 

  30. Madsen K, Cornish A, Soper P, et al. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology. 2001;121(3):580–591.

    Article  PubMed  CAS  Google Scholar 

  31. Schultz M, Veltkamp C, Dieleman LA, et al. Lactobacillus plantarum 299 V in the treatment and prevention of spontaneous colitis in interleukin-10-deficient mice. Inflamm Bowel Dis. 2002;8:71–80.

    Article  PubMed  Google Scholar 

  32. Saverymuttu SH, Camilleri M, Rees H, Lavender JP, Hodgson HJ, Chadwick VS. Indium 111-granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel disease. A comparison with colonoscopy, histology, and fecal indium 111-granulocyte excretion. Gastroenterology. 1986;90:1121–1128.

    PubMed  CAS  Google Scholar 

  33. Souza HS, Elia CC, Spencer J, MacDonald TT. Expression of lymphocyte-endothelial receptor-ligand pairs, alpha4beta7/MAdCAM-1 and OX40/OX40 ligand in the colon and jejunum of patients with inflammatory bowel disease. Gut. 1999;45(6):856–863.

    Article  PubMed  CAS  Google Scholar 

  34. Bento AF, Leite DF, Claudino RF, Hara DB, Leal PC, Calixto JB. The selective nonpeptide CXCR2 antagonist SB225002 ameliorates acute experimental colitis in mice. J Leukoc Biol. 2008;84(4):1213–1221.

    Article  PubMed  CAS  Google Scholar 

  35. Feighery LM, Smith P, O’Mahony L, Fallon PG, Brayden DJ. Effects of Lactobacillus salivarius 433118 on intestinal inflammation, immunity status and in vitro colon function in two mouse models of inflammatory bowel disease. Dig Dis Sci. 2008;53(9):2495–2506.

    Article  PubMed  Google Scholar 

  36. Madsen KL, Doyle JS, Jewell LD, Tavernini MM, Fedorak RN. Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology. 1999;116(5):1107–1114.

    Article  PubMed  CAS  Google Scholar 

  37. McCarthy J, O’Mahony L, O’Callaghan L, et al. Double-blind, placebo-controlled trial of two probiotic strains in interleukin-10 knockout mice and mechanistic link with cytokine balance. Gut. 2003;52(7):975–980.

    Article  PubMed  CAS  Google Scholar 

  38. Gupta P, Andrew H, Kirschner BS, Guandalini S. Is Lactobacillus GG helpful in children with Crohn’s disease? Results of a preliminary, open-label study. J Pediatr Gastroenterol Nutr. 2000;31(4):453–457.

    Article  PubMed  CAS  Google Scholar 

  39. Miele E, Pascarella F, Giannetti E, Quaglietta L, Baldassano RN, Staiano A. Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis. Am J Gastroenterol. 2009;104(2):437–443.

    Article  PubMed  CAS  Google Scholar 

  40. van Assche G, Rutgeerts P. Antiadhesion molecule therapy in inflammatory bowel disease. Inflamm Bowel Dis. 2002;8(4):291–300.

    Article  PubMed  Google Scholar 

  41. Okada Y, Tsuzuki Y, Miyazaki J, et al. Propionibacterium freudenreichii component 1,4-dihydroxy-2-naphthoic acid (DHNA) attenuates dextran sodium sulphate induced colitis by modulation of bacterial flora and lymphocyte homing. Gut. 2006;55(5):681–688.

    Article  PubMed  CAS  Google Scholar 

  42. Nakamura M, Saito H, Kasanuki J, et al. Cytokine production in patients with inflammatory bowel disease. Gut. 1992;33:933–937.

    Article  PubMed  CAS  Google Scholar 

  43. Ando T, Jordan P, Wang Y, et al. MAdCAM-1 expression and regulation in murine colonic endothelial cells in vitro. Inflamm Bowel Dis. 2005;11:258–264.

    Article  PubMed  CAS  Google Scholar 

  44. Pathmakanthan S, Li CK, Cowie J, Hawkey CJ. Lactobacillus plantarum 299: beneficial in vitro immunomodulation in cells extracted from inflamed human colon. J Gastroenterol Hepatol. 2004;19(2):166–173.

    Article  PubMed  Google Scholar 

  45. Peña JA, Rogers AB, Ge Z, et al. Probiotic Lactobacillus spp. diminish Helicobacter hepaticus-induced inflammatory bowel disease in interleukin-10-deficient mice. Infect Immun. 2005;73(2):912–920.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by the National Key Basic Research Plan Program of China (973 Program), No. 2008CB517403, and the Special Foundation for Academician Jie-Shou Li (Intestinal Barrier Research), No. LJS_2009001.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Huan-Long Qin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chu, ZX., Chen, HQ., Ma, YL. et al. Lactobacillus plantarum Prevents the Upregulation of Adhesion Molecule Expression in an Experimental Colitis Model. Dig Dis Sci 55, 2505–2513 (2010). https://doi.org/10.1007/s10620-009-1063-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-009-1063-2

Keywords

Navigation